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Summary 
Coxsackie virus is a member of Enterovirus genus with high prevalence among 
population. Recent data indicate that this virus may partially be responsible for the incidence of 
type I diabetes. Taking in consideration the 5.3% increase of diabetic patients per year, every 
possible cause should be taken in consideration. A review of studies of Coxsackie viruses 
regarding their possible role in the development of type I diabetes is presented in this article. 
 
Rezumat 
Rolul virusului Coxsakie în dezvoltare diabetului zahărat de tip I 
Virusul Coxsackie este un membru de genul Enterovirus cu prevalenţă înaltă în populaţie. 
Date recente indică faptul că acest virus poate fi parţial responsabil pentru incidenţa de diabetul 
zahărat de tip I. Luînd în considerarea că creşterea pacienţilor cu diabetul zaharat este 5.3% 
anual fiecare cauză ar trebui să fie luată în considerare. În acest articol este prezentată o revizuire 
a studiilor de virusuri Coxsackie privind la rolul acestora în dezvoltarea de diabetul zaharat de tip 
I. 
Intoduction 
            Coxsackie viruses have been described in the 1948-49 by Gilbert, a researcher from New 
York. He discovered them from the intestine of children with poliomyelitis-like disease. G. 
Dalldorf with G. Sikls were looking for a method of treating polio. Despite the complete 
morphological similarity with polio virus, Coxsackie viruses have a different antigenic structure. 
A new family of viruses has been given the name Coxsackie, on behalf of a small town in the 
state of New York, where G. Dalldorf identified the first strains from fecal samples. 
Coxsackie virus belongs to the picornavirus family, genus Enterovirus. It has 4 protein 
forming the capsid about 30 nm long, which surrounds a single RNA molecule the size of 7.5 kb. 
Coxsackie viruses are divided into two groups A and B. Group A consists of 23 serotypes. The B 
group consists of at least 6 serotypes. Of these groups A9, B1, B2, B3, B4, B5 are considered to 
be related to first type of diabetes [1, 2, 3]. 
Coxsakie viruses have a broad area of distribution and high levels of morbidity in the 
population, especially in the warmer months. Depending on the patient's age and serotype of the 
virus the sickness rate varies from 2-100%. It is important to mention that 60% of patients have 
subclinical presentation of the disease. Coxsackie virus is one of the most common virus 
infections after polio virus [1]. 
             Recent years are marked with the increased number of evidence in favor that diabetes is 
a polietiological disease. The incidence of diabetes increases 5.3% per year. Overall incidence in 
the population varies between 1.6-30.9%, depending on the country. I type diabetes (T1D) is 




The pancreas is an exocrine and endocrine organ. The endocrine part of the pancreas is 
presented by a group of cells that form islets of islets of Langerhans. Among these cells are the 
β-cells which play the key role in the development of T1D. 
β-cells are the only cell type in the body capable of producing insulin. Insulin is a 
hormone with a wide range of metabolic effects. Insulin acts my several molecular mechanism 
thus supporting aminoacid, lipid and carbohydrate transport, storage etc. One of the most 
important functions of insulin is to provide glucose transport into cells. Without this hormone the 
use of glucose as an energy source is practically impossible, which causes an increase in blood 
sugar level - hyperglycemia, with all the attendant complications. Among the T1D complications 
are listed cardiovascular, neural and kidney pathologies. Patients with T1D have an increased 
chance of myocardial infarction, strokes and end stage kidney disease. This makes T1D an 
important cause of mortality and morbidity among the population. 
 
The possible pathophysiology of T1D 
The exact mechanism by which the β-cells are attacked by immune system is not known. 
But the current theory proposes that Coxsackie virus causes a persistent infection of β-cells that 
activates the immune system. The most important theories are the theory of bystander damage 
and molecular mimicry.  
The theory of molecular mimicry is supported by the presence of similarities between 
Coxsackie virus protein 2C and β-cell protein GAD65. This leads to the synthesis of antibodies 
against a protein that is actively synthesized by the pancreas.  
The bystander damage is another theory. Pancreatic cells infected by Coxsackie virus 
RNA can lead to pancreatitis, but due to the damage a large amount of cytokines is released by 
islets cells.  
An alternative theory was recently proposed in which thymus is considered to be main 
organ affected by the virus. This can lead to the damage of T regulatory cells. The current data 
shows that infection can lead to thymus anomalies which can modify the tolerance of the body to 
its own cells. This can result in mutant T cells that cannot properly identify foreign pathogens 
from the cells of the organism. 89% of cases of T1D are autoimmune. This partially can be 
explained by abnormal T cells that play one of the dominant roles in pathophysiology of T1D [4, 
5]. 
Clinical presentations 
The incubation period for enterovirus infection is 2-35 days, an average of 3 to 12. Most 
infections are asymptomatic. Clinically significant symptoms are usually the same as the 
common cold. Enterovirus infections are the second most common causative agent of severe 
acute respiratory syndrome (SARS). 
            However, a small percentage of patients may have severe complications or other clinical 
manifestations of the disease. These may include serous enteroviral meningitis, herpangina, 
epidemic myalgia. Due to the fact that the main route of infection is through the gastrointestinal 
tract (GIT) Coxsackie viruses can cause enteritis with diarrhea and abdominal pain.  
Coxsackie viruses are resistant to the acidity of the stomach and may be asymptomatic 6 
weeks or more in the GIT. In some cases only virus RNA can be identified using PCR which 
indicates that the virus doesn’t replicate properly and sometimes makes mistakes. This can 
further complicate diagnostic procedures. 
The virus has the ability to infect up to 100 different types of tissues which makes it a 
highly contagious infection [6, 7]. 
 
Discussions 
            The theory that diabetes is associated with enteroviruses was proposed in 1969 (Gamble 




There are several reasons why T1D can be caused by enterovirus infections. Less than 
10% of genetically predisposed people develop diabetes during their life.Concordance in 
homozygous twins is 30-50%.  
The incidence of T1D increases in late summer and early autumn, at the peak of 
enteroviral disease. This leads to the suggestion that the development of T1D has not only 
genetic factors involved but also epidemiological [8]. 
             According to I. Mena et al., 2000 up to 50% of children with autoimmune diabetes have 
antibodies to the Coxsackie virus, as well as 20-34% of patients with pancreatitis [9]. 
            Several authors have noted an increase in the secretion of IL-10 and TNF-a by cells of 
the pancreas infected with Coxsackie viruses, which results in the inflammatory process, but not 
always in the destruction of b-cells. These b-cells sometimes lose the ability to respond to 
increased blood glucose levels [10, 11]. 
Studies of DAISY (The Diabetes and Autoimmunity Study in the Young) indicates that 
of the 140 children who were found to have antibodies about 50 became sick with diabetes in the 
period of 4.2 years.  
E. Witso et al., 2007 indicates a high risk of enterovirus infections. Of the 113 newborns 
about 58 had enterovirus infections. PCR test detected the presence of RNA viruses in fecal 
samples in 11.3%. Of these, were allocated 22 different serotype, including a 4.8% B type [10]. 
M. Elfving et al., 2008 indicated an increased risk of developing diabetes for boys whose 
mothers were IgM positive for the virus. The same effect was seen in mice [11]. 
The group with diabetes was more likely than the control group to be tested positive for 
enterovirus RNA in their system. Often the test was positive for RNA, but not for the proteins of 
the virus, indicating virus replication errors. The result indicates that the majority of diabetes 
patients have long-term infection of the intestinal mucosa, which can lead to the development of 
the disease [12]. 
Nevertheless, not all Coxsackie viruses have the same effect on β-cells. So Coxsackie 
virus B3 besides autoimmune effect may in some cases make the body resistant to the 
development of diabetes in the case of B4 virus infection. This effect has led to a theory in which 
it was suggested that low hygiene levels can lead to an increased incidence of some of the 
Coxsackie virus infection. But due to certain favorable factors: time, period of infection, the 
presence of a co-infection could lead to the development of immunity to the virus, and thus the 
T1D caused by the Coxsackie virus.  
This can explain why in some countries with a high level of hygiene may be more 
patients with T1D, such as in Finland and Sweden. 
Additionally this can be used in future therapies against Coxsakie virus and thus can 
lower the chance of developing T1D. 
 
Conclusion 
            In our work, we showed one of the possible reasons for increase in the incidence of 
diabetes. Different Coxsackie virus models show different impact on the development of 
diabetes.  
Several authors indicate that this virus can cause autoimmune diseases, with reasonable 
data from clinical and experimental study. On the other hand, not all studies investigated a large 
number of patients. Other studies didn’t compare the diseased patients with a control group of 
healthy individuals to lower the percent of mistakes.  
A number of authors in their studies denied the relationship between Coxsackie virus and 
T1D. It should be noted that more detailed analysis of this problem can lead to more precise and 
accurate data.  
There remain a number of very important subjects for discussion, such as whether the 
Coxsackie virus affects all the patients equally, or some of them have some type of immunity. 




of providing significant protection from the infection. If they exist then they should be used to 
reduce morbidity of T1D, even if the virus is responsible for only a small percentage of diabetes.  
T1D can be adequately reduced, significantly facilitating lives of patients who might get 
a lifetime health improvement. Additionally this can positively affect the overall health in 
different countries with high incidence of T1D. 
Another proposition is the development of a vaccine against the virus and specific 
antiviral therapy drugs. This can significantly reduce the current diabetes pandemic. 
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Summary 
Characteristics of immune reactivity and pre-immune  
resistance in patients with pulmonary tuberculosis 
Tuberculosis is one of the main goals of worldwide infection control and a primary public 
health problem which continues to remain the disease with a high mortality rate and significant 
